AI assistant
Sending…
Alkermes plc. — Director's Dealing 2026
Jan 2, 2026
31048_dirs_2026-01-02_637c69c3-9c9e-43f8-bbb2-fb6fa3e9e666.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2026-01-02
Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-02 | Ordinary Shares | S | 4000 | $28.00 | Disposed | 61740 | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.
More from Alkermes plc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27